Overview
Background
Profile Summary
Dr Sandro Porceddu is an internationally recognised radiation oncologist and a leading authority in head and neck and skin cancer. With over 20 years experience in medicine his areas of clinical expertise include head and neck cancer, skin cancer, sarcoma and lymphoma. He is currently a senior radiation oncologist and Director of radiation oncology research at the Princess Alexandra Hospital, Brisbane, Professor of Medicine, University of Queensland and Associate Editor for the International Head and Neck journal, Oral Oncology.
Dr Porceddu is a nationally and internationally recognised cancer advocate through his involvement in high-level committees, engagement with key policymakers, community education and media roles.
Career Summary
Professor Porceddu completed his medical degree at Monash University before undertaking his residency at Monash Medical Centre, Melbourne. He commenced his specialist training in radiation oncology at the Peter MacCallum Cancer Centre in 1996 and was made Fellow of the Royal Australian and New Zealand College of Radiologists, Faculty of Radiation Oncology in 2000. After working as a consultant radiation oncologist at PeterMac for several years he moved to the Princess Alexandra Hospital in 2004.
Professional Committees and Organisations
Professor Porceddu has been the President of the Clinical Oncology Society of Australia (COSA), the peak organisation for cancer-related health professionals, and the Trans Tasman Radiation Oncology Group (TROG), one of the largest cancer collaborative trials group in Australia/New Zealand. He has served on numerous national and international professional and academic committees including the board of the Cancer Council of Australia, the National Cancer Expert Reference Group for the Commonwealth and the International Union for the Control of Cancer (UICC) TNM Expert Advisory Panel.
Currently, he is the Chair of the Cancer Council Queensland Co-operative Oncology Group, a committee that provides over $1.2M per annum to support clinical research throughout Queensland and is on the board of the of the Head and Neck Cancer InterGroup (HNCIG), a group of leading world cancer experts dedicated to promoting the global harmonisation of head and neck cancer research and treatment.
Academic Highlights
Professor Porceddu runs an active clinical research program with over 150 peer-review articles, book chapters, published abstracts, invited reviews and commentaries. He has received invitations to speak at major international conferences such as the American Society of Clinical Oncology (ASCO) meeting and publish in prestigious journals such as the Lancet Oncology and Journal of Clinical Oncology.
Awards
Trans Tasman Radiation Oncology Group Outstanding Contribution
American Head and Neck Society Chris O’Brien Travelling Scholar
Pre-eminent status by Queensland Health
Rouse Fellowship, Royal Australian and New Zealand College of Radiologists
Teaching
Dr Porceddu has had a life-long commitment to teaching and is a supervisor and mentor to Doctor of Philosophy and Master of Philosophy candidates, Clinical Research Fellows, MBBS Honours students, resident, registrars and other allied health professionals.
Availability
- Professor Sandro Porceddu is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Science, Monash University
- Bachelor of Medicine and Surgery and Medical Science, Monash University
- Doctoral Diploma of Medicine, The University of Queensland
Research impacts
Dr Porceddu’s has been investigating methods to reduce the morbidity of treatment, improve cure rates and quality of life for cancer patients. He runs an active head and neck/skin cancer research program and is the principal investigator of numerous trials including an NHMRC-supported Randomised Phase III trial on head and neck skin cancer (POST TROG 05.01). In line with his research goals he has been examining the integration of radiation therapy and new technologies in the management of head and neck cancer and has received his Doctorate of Medicine (MD) on this topic with UQ. His current research on Positron Emission Tomography in the management of the neck following chemo-radiotherapy has been internationally recognised and incorporated into the USA National Comprehensive Cancer Network (NCCN) guidelines. He has been the recipient of over $3.91M in competitive funding, including one recently closed and two open NHMRC grants.
Works
Search Professor Sandro Porceddu’s works on UQ eSpace
2013
Journal Article
Developing an adaptive radiotherapy technique for virally mediated head and neck cancer
Brown, E., Porceddu, S., Owen, R. and Harden, F. (2013). Developing an adaptive radiotherapy technique for virally mediated head and neck cancer. Journal of Medical Imaging and Radiation Sciences, 44 (3), 134-140. doi: 10.1016/j.jmir.2013.04.001
2013
Journal Article
Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer
Hong, A. M., Martin, A., Armstrong, B. K., Lee, C. S., Jones, D., Chatfield, M. D., Zhang, M., Harnett, G., Clark, J., Elliott, M., Milross, C., Smee, R., Corry, J., Liu, C., Porceddu, S., Vaska, K., Veness, M., Morgan, G., Fogarty, G., Veivers, D., Rees, G. and Rose, B. (2013). Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Annals of Oncology, 24 (1) mds205, 215-219. doi: 10.1093/annonc/mds205
2013
Journal Article
International comparisons of the incidence and mortality of sinonasal cancer
Youlden D.R., Cramb S.M., Peters S., Porceddu S.V., Moller H., Fritschi L. and Baade P.D. (2013). International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiology, 37 (6), 770-779. doi: 10.1016/j.canep.2013.09.014
2013
Conference Publication
Single agent panitumumab in patients with incurable cutaneous squamous cell carcinoma: A single centre phase II study
Foote, M., McGrath, M., Guminski, A., Hughes, B., Meakin, J., Thomson, D., Simpson, F. and Porceddu, S. (2013). Single agent panitumumab in patients with incurable cutaneous squamous cell carcinoma: A single centre phase II study. 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, Amsterdam Netherlands, Sep 27-Oct 01, 2013. Oxford United Kingdom: Pergamon Press. doi: 10.1016/S0959-8049(13)70065-0
2012
Journal Article
Long-term functional outcomes and the patient perspective following altered fractionation with concomitant boost for oropharyngeal cancer
Cartmill, Bena, Cornwall, Petrea, Ward, Elizabeth, Davidson, Wendy and Porceddu, Sandro (2012). Long-term functional outcomes and the patient perspective following altered fractionation with concomitant boost for oropharyngeal cancer. Dysphagia, 27 (4), 481-490. doi: 10.1007/s00455-012-9394-0
2012
Journal Article
PET in decision making for neck dissection after radiation treatment
Adams, G. and Porceddu, S.V. (2012). PET in decision making for neck dissection after radiation treatment. PET Clinics, 7 (4), 411-423. doi: 10.1016/j.cpet.2012.06.004
2012
Journal Article
Swallowing, nutrition and patient-rated functional outcomes at 6 months following two non-surgical treatments for T1-T3 oropharyngeal cancer
Cartmill, Bena, Cornwell, Petrea, Ward, Elizabeth, Davidson, Wendy and Porceddu, Sandro (2012). Swallowing, nutrition and patient-rated functional outcomes at 6 months following two non-surgical treatments for T1-T3 oropharyngeal cancer. Supportive Care in Cancer, 20 (9), 2073-2081. doi: 10.1007/s00520-011-1316-4
2012
Journal Article
Radiotherapy - maintaining focus throughout the cancer journey
Adams, Gerard and Porceddu, Sandro V. (2012). Radiotherapy - maintaining focus throughout the cancer journey. Cancer Forum, 36 (2), 1-3.
2012
Journal Article
A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer
Cartmill, Bena, Cornwell, Petrea, Ward, Elizabeth, Davidson, Wendy and Porceddu, Sandro (2012). A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia, 27 (1), 32-45. doi: 10.1007/s00455-011-9333-5
2012
Conference Publication
A study of human Papillomavirus (Hpv) 16 status in squamous cell carcinoma of the oropharynx in patients presenting to the head and neck cancer service Princess Alexandra Hospital, Brisbane, Queensland, Australia
Rowan, A., Porceddu, S., V, Pryor, D., I and Logan, J. (2012). A study of human Papillomavirus (Hpv) 16 status in squamous cell carcinoma of the oropharynx in patients presenting to the head and neck cancer service Princess Alexandra Hospital, Brisbane, Queensland, Australia. UCD School of Medicine & Medical Science, Summer Student Research Awards 2012, Dublin, Ireland, 4 October 2012. London, United Kingdom: Springer U K. doi: 10.1007/s11845-012-0861-2
2012
Conference Publication
Living with dysphagia: insights and implications for Speech Pathology Services for patients in the Survivorship Phase of head and neck cancer
Nund, Rebecca, Ward, Elizabeth, Scarinci, Nerina, Cartmill, Bena, Kuipers, Pim and Porceddu, Sandro (2012). Living with dysphagia: insights and implications for Speech Pathology Services for patients in the Survivorship Phase of head and neck cancer. COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho–Oncology, Brisbane QLD, Australia, 13-15 November 2012. West Sussex, United Kingdom: Wiley-Blackwell Publishing.
2011
Journal Article
Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma
Pryor, D.I., Burmeister, E., Burmeister, B.H., Poulsen, M.G. and Porceddu, S.V. (2011). Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma. Oral Oncology, 47 (10), 984-987. doi: 10.1016/j.oraloncology.2011.07.023
2011
Journal Article
The emerging era of personalized therapy in squamous cell carcinoma of the head and neck
Pryor, David I., Solomon, Benjamin and Porceddu, Sandro V. (2011). The emerging era of personalized therapy in squamous cell carcinoma of the head and neck. Asia-Pacific Journal of Clinical Oncology, 7 (3), 236-251. doi: 10.1111/j.1743-7563.2011.01420.x
2011
Journal Article
Pathological occult neck disease in patients with metastatic cutaneous squamous cell carcinoma to the parotid
Kirke, Diana N., Porceddu, Sandro, Wallwork, Benjamin D., Panizza, Benedict and Coman, William B. (2011). Pathological occult neck disease in patients with metastatic cutaneous squamous cell carcinoma to the parotid. Otolaryngology - Head and Neck Surgery, 144 (4), 549-551. doi: 10.1177/0194599810395361
2011
Book Chapter
Functional imaging of head and neck cancer with positron emission
Porceddu, Sandro V., Waldron, John and Hicks, Rodney J. (2011). Functional imaging of head and neck cancer with positron emission. Multidisciplinary management of head and neck cancer. (pp. 197-214) New York, United States: Demos Medical.
2011
Journal Article
Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy
Porceddu, Sandro V., Pryor, David I., Burmeister, Elizabeth, Burmeister, Bryan H., Poulsen, Michael G., Foote, Matthew C., Panizza, Benedict, Coman, Scott, McFarlane, David and Coman, William (2011). Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head and Neck, 33 (12), 1675-1682. doi: 10.1002/hed.21655
2011
Conference Publication
Estimation of EGF receptor expression and trafficking dysregulation in live tissue samples of cutaneous SCC and precursor lesions
Gaffney, D. C., Barry, R., Lambie, D., Porceddu, S. V., Foote, M., Strutton, G., Saunders, N. A., Soyer, H. P. and Simpson, F. (2011). Estimation of EGF receptor expression and trafficking dysregulation in live tissue samples of cutaneous SCC and precursor lesions. Australasian College of Dermatologists Biennial Spring Conference 2011, Hobart, Australia, 13-16 October 2011. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-0960.2011.00810.x
2011
Conference Publication
A prospective examination of swallowing nutrition and patient-rated function following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer
Cartmill, Bena, Cornwell, P., Ward, L.., Davidson, W. and Porceddu, S. (2011). A prospective examination of swallowing nutrition and patient-rated function following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia Research Society 2011, San Antonio, TX USA, 3-5 March 2011. New York, NY USA: Springer New York. doi: 10.1007/s00455-011-9345-1
2010
Journal Article
Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin
Foote, Matthew, Harvey, Jennifer, Porceddu, Sandro, Dickie, Graeme, Hewitt, Susan, Colquist, Shonie, Zarate, Dannie and Poulsen, Michael (2010). Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin. International Journal of Radiation Oncology Biology Physics, 77 (3), 677-684. doi: 10.1016/j.ijrobp.2009.05.067
2010
Journal Article
Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?
Porceddu, Sandro V. (2010). Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?. Asia-Pacific Journal of Clinical Oncology, 6 (2), 75-76. doi: 10.1111/j.1743-7563.2010.01294.x
Funding
Past funding
Supervision
Availability
- Professor Sandro Porceddu is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Completed supervision
-
2017
Master Philosophy
Pre-radiotherapy dental extractions and osteoradionecrosis: a retrospective analysis and cross-sectional study on quality of life
Associate Advisor
-
2012
Doctor Philosophy
Swallowing, nutrition, and patient-rated functional outcomes in head and neck cancer patients treated with altered fractionation radiotherapy
Associate Advisor
Other advisors: Professor Elizabeth Ward
Media
Enquiries
For media enquiries about Professor Sandro Porceddu's areas of expertise, story ideas and help finding experts, contact our Media team: